Gemcitabine: all 1,576 studies that test it
Page 10 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic CancerStatus unknownNCT01934634Phase 1
- A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.CompletedNCT01929421Phase 2
- Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic CancerCompletedNCT01924260Phase 1
- Avastin+ GemAOD As First-Line Treatment in NK/T Cell LymphomaStatus unknownNCT01921790Phase 2
- Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01915134Phase 3
- Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer PatientsCompletedNCT01909830Phase 2
- Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic CancerCompletedNCT01908478Phase 1
- Chemoimmunotherapy and Radiation in Pancreatic CancerCompletedNCT01903083Phase 1
- Neoadjuvant Treatment in Resectable Pancreatic CancerTerminatedNCT01900327Phase 3
- A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With CholangiocarcinomasCompletedNCT01900158Phase 1
- Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT01893294Phase 1
- Molecularly Tailored Therapy for Pancreas CancerCompletedNCT01888978Phase 2
- Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or SurgeryCompletedNCT01888302Phase 1
- Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma PatientsStatus unknownNCT01884441Phase 2
- A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaActive, not recruitingNCT01878617Phase 2
- Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01872962Phase 3
- Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural MesotheliomaStatus unknownNCT01869023Phase 2
- Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsCompletedNCT01858883Phase 1/2
- Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPCStatus unknownNCT01854203Phase 2/3
- Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase ICompletedNCT01852890Phase 1
- Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerCompletedNCT01850303Phase 3
- Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell LymphomaCompletedNCT01846390Phase 1
- An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01844791Phase 2
- Tivozanib + Gemcitabine in Metastatic RCCWithdrawnNCT01834183Phase 2
- EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic CancerCompletedNCT01834170Phase 1
- Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic CancerWithdrawnNCT01830322Phase 2
- Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction ChemotherapyCompletedNCT01827553Phase 3
- ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerCompletedNCT01825603Phase 1
- Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerCompletedNCT01821612Early Phase 1
- A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node MetastasisStatus unknownNCT01821248Phase 2
- Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01815307Phase 2
- Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast CancerCompletedNCT01815242Phase 2
- Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaStatus unknownNCT01812018Phase 2
- Neoadjuvant Chemotherapy in Locally Advanced Bladder CancerCompletedNCT01801644Not applicable
- The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung CancerCompletedNCT01797913Phase 2
- Adjuvant Effect of Chloroquine on GemcitabineCompletedNCT01777477Phase 1
- A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01770795Phase 2
- Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic CancerCompletedNCT01770132Phase 1
- BAY86-9766 Plus Gemcitabine Phase I Study in AsianCompletedNCT01764828Phase 1
- Sorafenib Combined With Chemotherapy for Renal Collecting Duct CarcinomaCompletedNCT01762150Phase 2
- Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryTerminatedNCT01739439Phase 1
- Adjuvant Post-radical Cystectomy Treatment for Bladder CancerCompletedNCT01734798Phase 3
- Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic CancerStatus unknownNCT01729481Phase 2
- CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II StudyStatus unknownNCT01719835Phase 2
- Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue SarcomaCompletedNCT01719302Phase 1/2
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic CancerCompletedNCT01715142Early Phase 1
- A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01713387Phase 1
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic CancerStatus unknownNCT01713218Early Phase 1
- Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant ChemotherapyCompletedNCT01710176Phase 3
- A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic DiseaseWithdrawnNCT01702714Phase 1
- The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder CancerCompletedNCT01697306Phase 2
- S-1, Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT01693419Phase 2
- Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic CancerTerminatedNCT01693276Phase 1/2
- Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue SarcomaCompletedNCT01684449Phase 1/2
- A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT01676259Phase 2
- Ultrasound-assisted Treatment of Inoperable Pancreatic CancerCompletedNCT01674556Phase 1
- Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT01660971Phase 1
- MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung CancerStatus unknownNCT01656551Phase 3
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
- Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
- Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT01633645Phase 2
- OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the PancreasWithdrawnNCT01600807Phase 1/2
- JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinCompletedNCT01599013Phase 2
- Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic CancerWithdrawnNCT01598584Phase 2/3
- GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest ChinaCompletedNCT01596868Phase 2
- Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid TumorsTerminatedNCT01573780Phase 1
- A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or LymphomaCompletedNCT01564251Phase 1
- Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second RelapseCompletedNCT01562990Phase 1/2
- Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLCompletedNCT01562977Phase 2
- Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical CarcinomaCompletedNCT01554410Phase 1
- Postoperative Proton Radiotherapy With Chemo for Pancreatic CancerCompletedNCT01553019Phase 2
- A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast CancerCompletedNCT01550848Phase 2
- Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01549093Phase 2
- Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic CancerCompletedNCT01547260Phase 1/2
- Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive LymphomasCompletedNCT01538641Phase 2
- Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially ResectableTerminatedNCT01531712Phase 2
- Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal CarcinomaCompletedNCT01528618Phase 3
- Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic CholangiocarcinomaTerminatedNCT01525069Phase 1
- Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1WithdrawnNCT01524575Phase 2
- Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid TumorStatus unknownNCT01511146Phase 2
- A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.WithdrawnNCT01510561Phase 1
- Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic CancerCompletedNCT01505413Phase 2
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersCompletedNCT01497392Phase 1
- Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerCompletedNCT01488552Phase 1/2
- Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer PatientsCompletedNCT01487785Phase 1
- A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal CancerCompletedNCT01472770Phase 2
- Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2
- Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic CancerCompletedNCT01442974Not applicable
- Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed UterineCompletedNCT01442662Phase 2
- Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginTerminatedNCT01434459Phase 1
- Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic CancerCompletedNCT01430052Phase 2
- Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid TumorsCompletedNCT01428427Phase 1
- Combination Therapy of Gemcitabine and Trabectedin in L-sarcomasCompletedNCT01426633Phase 1
- Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01424709Phase 2
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesCompletedNCT01421173Phase 1
- Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01417390Phase 2
- Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryCompletedNCT01416662Phase 2
- The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
- Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas CancerStatus unknownNCT01411072Not applicable
- Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase ExpressionStatus unknownNCT01401192Phase 2